Fundraising FoxAstrivax Therapeutics
4 known investors
Find your way into Astrivax Therapeutics
Sign up to see every warm intro you have to Astrivax Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Astrivax Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Astrivax Therapeutics is a clinical-stage biopharmaceutical company developing immunotherapies to treat virus-driven cancers, particularly HPV16-associated cancers like cervical and head and neck cancer. The company's Launch-iT platform generates durable T-cell responses against virus-infected cells and is advancing toward clinical proof-of-concept.
Founders & leadership
HC
Hanne CallewaertFounder · Chief Executive OfficerHanne Callewaert holds a Master's degree in Biomedical Sciences, a PhD in Medical Sciences, and a Master's in Intellectual Property Law. She brings more than 20 years of experience across the life sciences industry, including roles at GSK Vaccines, Oxurion, Oncurious, and as founding CEO of Astrivax Therapeutics, as well as COO experience at a public company.
JN
Johan NeytsFounder
KD
Kai DallmeierFounder
Investors · 4
Fund+listed by Fund+Leuven · $5.5M – $16.5M
How we know: Fund+'s portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
PMVlisted by PMVBrussels
How we know: PMV's portfolio page · funding news · Not right? Tell us
Frequently asked questions
- What does Astrivax Therapeutics do?
- Astrivax Therapeutics is a clinical-stage biopharmaceutical company developing immunotherapies to treat virus-driven cancers, particularly HPV16-associated cancers like cervical and head and neck cancer. The company's Launch-iT platform generates durable T-cell responses against virus-infected cells and is advancing toward clinical proof-of-concept.
- Who founded Astrivax Therapeutics?
- Astrivax Therapeutics was founded by Hanne Callewaert.
- Who are Astrivax Therapeutics's investors?
- Astrivax Therapeutics's investors include Fund+, Korys, PMV, V-Bio Ventures.